2,4-diamino-5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine,
brodimoprim,
Ro 10-5970,
Ro-10-5970,
Brodimoprim,
56518-41-3,
Brodimoprima,
Brodimoprime,
Brodimoprimum,
Bromdimoprim,
Unitrim,
Ro 10-5970,
5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine-2,4-diamine,
Hyprim,
Brodimoprim [INN],
Ro 105970,
UNII-V1YC7T6LLI,
Brodimoprime [INN-French],
Brodimoprimum [INN-Latin],
Brodimoprima [INN-Spanish],
Ro-10-5970,
2,4-Diamino-5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine,
EINECS 260-238-8,
V1YC7T6LLI,
BRN 0760113,
C13H15BrN4O2,
CHEMBL31891,
5-((4-Bromo-3,5-dimethoxyphenyl)methyl)-2,4-pyrimidinediamine,
Brodimoprim (INN),
5-[(4-bromo-3,5-dimethoxy-phenyl)methyl]pyrimidine-2,4-diamine,
5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]-2,4-pyrimidinediamine,
2,4-Pyrimidinediamine, 5-((4-bromo-3,5-dimethoxyphenyl)methyl)-,
2,4-Pyrimidinediamine, 5-[(4-bromo-3,5-dimethoxyphenyl)methyl]-,
AC1L2AE4,
AC1Q25IZ,
SCHEMBL49613,
5-25-13-00394 (Beilstein Handbook Reference),
ZINC5824,
CTK6J6613,
DTXSID20205070,
BFCRRLMMHNLSCP-UHFFFAOYSA-N,
CHEBI:131726,
BDBM50027970,
AKOS016013929,
API0001762,
NCGC00238470-01,
AJ-08255,
AN-40167,
AX8118706,
LS-134970,
FT-0663605,
D07238,
518B413,
5-(4-Bromo-3,5-dimethoxybenzyl)-2,4-pyrimidinediamine,
2,4-diamino-5-(4-bromo-3,5-dimethoxybenzyl)-pyrimidine,
5-(4-Bromo-3,5-dimethoxy-benzyl)-pyrimidine-2,4-diamine,
5-[(4-bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine,
D06QKV,
C13-H15-Br-N4-O2,
CID68760,
C037079,